Compositions and Methods for Treating Central Nervous System Disorders
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 17/823,080, filed Aug 29, 2022. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,337,987 | Compositions and Methods for Treating Central Nervous System Disorders In force · High confidence | Lipocine Inc. | In force | High confidence | ||
| US 11,478,485 | Compositions and Methods for Treating CNS Disorders In force · Medium confidence | Lipocine, Inc. | In force | Medium confidence | ||
| US 12,208,103 | Compositions and Methods for Treating CNS Disorders In force · Medium confidence | Lipocine Inc. | In force | Medium confidence | ||
| US 12,527,805 | Compositions and Methods for Treating CNS Disorders In force · Medium confidence | Lipocine, Inc. | In force | Medium confidence | ||
| US 11,969,434 | Oral Allopregnanolone Compositions and Methods of Use In force · High confidence | Lipocine, Inc. | In force | High confidence | ||
| US 12,186,327 | Oral Allopregnanolone Compositions and Methods of Use In force · Low confidence | Lipocine Inc. | In force | Low confidence | ||
| US 12,409,185 | Oral Allopregnanolone Compositions and Methods of Use In force · Low confidence | Lipocine, Inc. | In force | Low confidence | ||
| US 12,714,717 | 3Alpha-OH-5Beta-Pregnan-20-One Compositions and Methods for Treating Central Nervous System Disorders In force · Medium confidence | Lipocine, Inc. | In force | Medium confidence | ||
| Application 17/723,203 | 3Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders Pending Not granted | Lipocine, Inc. | Pending | Not granted | ||
| Application 17/929,895 | Compositions and Methods for Treating CNS Disorders Abandoned Abandoned May 15, 2026 | Lipocine Inc. | Abandoned | Abandoned May 15, 2026 | ||
| 3 more patents in this group · Pro | ||||||
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13.
8 of these are in force and held by Lipocine Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.